Symposium Addresses Unique Needs of Young Adults with Rheumatic Diseases PDF Print E-mail
Wednesday, 05 October 2011 07:55

The Arthritis Foundation is sponsoring the 2nd Annual Arthritis in PrimeTime symposium on Saturday, October 22 at the Long Beach Renaissance Hotel in Long Beach. This premier educational and motivational event fosters active and fulfilling lives for young adults (ages 17-45 years old) affected by arthritis, fibromyalgia, lupus, scleroderma, ankylosing spondylitis and other chronic diseases. 



The event's theme is "Making My Work Work–"Work" being broadly defined as college, disability, life transitions, home-making or career. Led by top medical experts and advocates, informational sessions will educate hundreds of participants with chronic diseases about diverse lifestyle issues (including transition from college to the job market, workplace success, social relationships and health insurance issues), as well as research updates and medical treatments for pain management.  

"Most people do not know that arthritis is the #1 cause of work disability in the United States," said Arthritis in PrimeTime chair, Amye Leong, M.B.A. "Arthritis in PrimeTime is a positive, motivating event designed to help over 11 million young people affected with arthritis and other rheumatic diseases lead active, productive lives."  Ms. Leong, who was wheelchair-bound by rheumatoid arthritis, is today the international spokesperson for the United Nations Bone and Joint Decade.

Arthritis in PrimeTime is made possible through the Jane Wyman Trust and Pfizer, and is conducted in partnership with LupusLA, National Fibromyalgia Association, Scleroderma Foundation, Spondylitis Association of America, and Arthritis Introspective. 

The symposium begins at 9 a.m., and ends with an inspirational closing address by Matt Iseman, M.D., renowned comedian and host of Style Network's "Clean House."  Tickets are $25 each or $40 per couple. 

For more information or to register for this event, visit www.arthritisinprimetime.org or contact Jennifer Ziegler at the Arthritis Foundation at 323.954.5760 Ext. 243.

Source: PRNewswire


 
More articles :

» Primary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges

Cristina Rigamonti, Dimitrios P. Bogdanos, Maria G.Mytilinaiou, Daniel S. Smyk, Eirini I. Rigopoulou, and Andrew K. BurroughsReceived 3 June 2011; Accepted 7 September 2011Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease...

» Rare Disease Research Teams Receive Over $17m In Funding

(CIHR) has formed 9 new research teams that will focus on rare diseases. Funding from the CIHR will total $15.4 million over five years, primarily through the Institute of Genetics and the Institute of Nutrition, Metabolism, and Diabetes, while...

» The registry of the German Network for Systemic Scleroderma

N. Hunzelmann, E. Genth, T. Krieg, W. Lehmacher, I. Melchers, M. Meurer, P. Moinzadeh, U. Mu¨ ller-Ladner, C. Pfeiffer, G. Riemekasten, E. Schulze-Lohoff, C. Sunderkoetter, M. Weber, M. Worm, P. Klaus, A. Rubbert, K. Steinbrink, B. Grundt, R. Hein,...

» Autoimmune Diseases May Increase Cancer Risk

A new study reveals that patients with certain autoimmune diseases are more likely to develop cancer. The new information could help doctors diagnose cancer at a much earlier stage.Two years ago, 67- year- old Dorothy Adams noticed a thickening and...

» Immunosuppressive Medications During Pregnancy and Lactation In Women with Autoimmune Diseases

Amy B Elliott & Eliza F Chakravarty10.2217/WHE.10.24 © 2010 Future Medicine LtdWomen's Health (2010) 6(3), 431–442Most autoimmune diseases predominantly affect females. Many of these diseases occur in women who have the potential to become...

» Capillaroscopy, Autoantibody Findings Predict Raynaud's Progression

Abnormal findings on nailfold and the presence of scleroderma-specific autoantibodies in patients presenting with new-onset without overt connective tissue disease are powerful independent predictors of progression to definite .A landmark Canadian...